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We describe the anesthetic management of a patient with severe myasthenia gravis and tracheal stenosis; the patient was
scheduled for direct laryngoscopy and dilatation. The combination of myasthenia gravis and tracheal obstruction presents several
diﬃculties for anesthetic management. The airway is shared; therefore, any complications are also shared by the anesthesiologist
and bronchoscopists. The potential for respiratory compromise in patients undergoing the two procedures requires that
anesthesiologists be familiar with the underlying disease state, as well as the interaction of anesthetic and nonanesthetic drugs in
a case involving myasthenia gravis. We reviewed the literature and report our experience in this case. There is no strong evidence
for choosing one approach to general anesthesia over another for bronchoscopy. Careful preoperative planning and experience in
airway management and jet ventilation are crucial to prevent an adverse outcome and obtain favorable results.
1.Introduction
We present the anesthetic management of a patient with
severe myasthenia gravis (MG) and tracheal stenosis she
was scheduled for direct laryngoscopy and dilatation.
Institutional review board (IRB) approval is not required
by our institution for single case reports; therefore, written
patient permission was not obtained.
The combination of myasthenia gravis and tracheal ste-
nosis presents several challenges for the anesthesiologist.
Therefore, preoperative evaluation of the MG patient should
includeareviewoftheseverityofthepatient’sdiseaseandthe
treatment regimen. The case should therefore be reviewed
with the surgeon before formulating the anesthesia plan.
Speciﬁc attention should be paid to voluntary and respi-
ratory muscle strength. The patient’s ability to protect and
maintain a patent airway postoperatively may be compro-
mised if any bulbar involvement exists preoperatively.
Respiratory muscle strength can be quantiﬁed by pulmonary
function tests. Finally, it is critical to evaluate the severity of
the subglottic stenosis and the diﬃculty of the intubation.
2. Case Presentation
The patient was a 24-year-old female with a past medical
history of myasthenia gravis (MG) and asthma. Her history
included nine days of orotracheal intubation for myasthenia
exacerbation.Sheneededﬁveplasmaphoresisexchangesand
high doses of corticosteroids and azathioprine. Afterwards,
the patient was discharged home in stable condition.
At home, the MG was treated with oral pyridostigmine
60mg, 3times per day; prednisone 20mg daily in the morn-
ing; oral azathioprine 75mg twice per day.Later, she experi-
encedabouttwoweeksofprogressiveshortnessofbreathand
stridor, which worsened with a nonproductive cough.
She was admitted for diﬃculty in breathing and exam-
ined by an the ear, nose, and throat (ENT) team on arrival
at the emergency department. She was found to have severe
subglottic stenosis. A computerized tomography (CT) scan
of the neck on admission showed that severe subglottic
stenosis has developed with minimal cross-sectional diam-
eters of 4 × 5mm at the narrowest point (0.32cm) approx-
imately 75% narrowing of her trachea. Stenosis extended2 Case Reports in Anesthesiology
over a craniocaudal distance of 15mm. Beyond the stenosis,
the trachea and central airways were normal. This hour-
glass conﬁguration of the stenosis is very characteristic of
endotracheal intubation injury.
She was scheduled for microdirect laryngoscopy and
tracheostomy with tracheal and subglottic dilation, injection
of Depo-Medrol, and placement of mitomycin-C. The pre-
operative vital signs were BP 111/63; pulse 67; temperature
35.8◦C (axillary); respiratory rate 20; weight 67.586kg; SpO2
97% on room air. Airway assessment: Mallampati Score
(MP)1;neckfullROM;Airwayevaluation:showednosignif-
icant abnormalities. Her voice was mildly hoarse, with mild
biphasic stridor during sitting and supine position. Lung
ﬁeldswerecleartoauscultation.Resultsoftheneurologicand
musculoskeletal examination were normal, and no bulbar
weakness was evident.
After detailed discussion with the surgeon regarding the
planned surgical procedure with a patient whose recent his-
tory included MG exacerbation, we decided not use muscle
relaxants. After application of the standard American Society
of Anesthesiologist (ASA) monitors, we preoxygenated with
100% oxygen. General anesthesia was induced intravenous-
ly (i.v.) with midazolam 1mg, lidocaine 60mg, propofol
200mg. We veriﬁed easy mask ventilation with bag and
mask. General anesthesia was maintained with propofol/
remifentanilinfusion,andtitratedwiththedegreeofsurgical
stimulation and the patient’s hemodynamic response. We
started with propofol 300mcg/kg/min (IV) and remifen-
tanil 0.5mcg/kg/min. Hydrocortisone 100mg was given to
decrease airway edema. No neuromuscular blockers were
given during the surgery.
The surgeon started with suspension laryngoscopy,
sprayed lidocaine, passed the vocal cords, then completed a
rigid bronchoscopy. We ventilated the lungs using jet ven-
tilation through the ventilating bronchoscope. Initially, we
startedat20poundspersquareinch(PSI).However,thiswas
insuﬃcient to generate a good chest rise, although oxygen
saturation was in the 90s. We, therefore, decided to gradually
increase the PSI to 40, with a respiratory rate of 14–18
jets per minute, allowing adequate time for exhalation. We
monitored chest rise and oxygen saturation. We were able to
maintain oxygen saturation between 94% and 99%.
The patient’s larynx was examined and found to be
normal. Advancement of the scope to separate the true
vocal folds showed good exposure of the subglottis and
trachea. There was an approximately 2.5cm stenosis about
1cm distal to the glottis, and having 2 areas of focal webs.
Her trachea was approximately 60% to 70% stenosed, which
matched the preoperative CT scan. At the point, Depo-
Medrol 40mg/ML was injected into the 2 webs. Then a knife
was used to make radial cuts in these 2 webs. Next, the 10–
12mmballoonwasplacedintothestenoticareaunderapnea.
The patient’s saturation never dropped during this time.
Afterward, she was jet-ventilated without diﬃculty. Since we
used jet ventilation during the entire procedure, we were
concerned that subcutaneous emphysema would develop;
but there were no clinical signs of it.
A small mucosal tear was observed within the trachea
in the posterolateral position, but it was less than 1cm; we
therefore believed it would have little eﬀect on the patient’s
airway. The patient’s lungs were ventilated back with bag
and mask without diﬃculty. Surgery lasted one hour and the
estimated blood loss was 20mL. Throughout the procedure,
the patient received 1liter of crystalloid. Blood pressure was
maintained with mean blood pressure (MBP) between 70
and 80mmHg. Finally, the airway was suctioned and the
patient became fully awake in the operating room. She was
then transferred to the postanesthesia care unit for observa-
tion. Postoperatively, she remained in stable condition and
the stridor resolved. The patient was discharged home 2days
later.
3. Discussion
Myasthenia gravis (MG) is an autoimmune disease charac-
terized by weakness and fatigability of skeletal muscles, with
improvement following rest. It may be localized to speciﬁc
muscle groups or generalized. It has an estimated prevalence
of 1 in 20,000 [1], and aﬀects females more than males.
MG is caused by a decrease in the number of postsynaptic
acetylcholine receptors at the neuromuscular junction; this
decrease in turn reduces the capacity of the neuromuscular
end-plate to transmit the nerve signal. Initially, in response
to a stimulus resulting in depolarization, acetylcholine is
released presynaptically. In MG, the number of activated
postsynaptic receptors may be insuﬃcient to trigger a muscle
action potential [1].
Some clinicians choose not to administer anticholine-
sterase on the morning of surgery, in order to minimize the
need for muscle relaxants whereas others administer it for
psychological support of the patient. If the patient is poorly
controlled, a course of plasmapheresis may be beneﬁcial in
the preoperative period [2].
The steroid-dependent patient will require perioperative
coverage. Anxiolytic, sedative, and opioid premedications
are rarely given to patients who may have little respiratory
reserve. However, if the patient has primarily ocular symp-
toms, a small dose of benzodiazepine is acceptable [3].
Several general anesthetic techniques have been pro-
posed, although none have been demonstrated as superior to
the others. Some anesthesiologists prefer to avoid muscle
relaxants, instead using potent inhaled agents both for fa-
cilitating tracheal intubation and providing relaxation for
surgery. These agents allow neuromuscular transmission
to recover, and the agents are rapidly eliminated at the
end of surgery. In theory, desﬂurane and sevoﬂurane may
oﬀer some advantages, due to their low blood solubility.
Sevoﬂurane is probably more eﬀective than desﬂurane, due
to its lower incidence of excitatory airway reﬂexes during
inhalational induction [3].
It was very challenging to keep the patient relaxed with-
out muscle relaxants when the suspension laryngoscope was
introduced and airway manipulations were stimulated.
When required, small doses (10–25% of ED 95) of inter-
mediate-acting relaxants are titrated to the evoked MMG or
EMG for both intubation and surgical relaxation. Whether
or not to reverse residual neuromuscular blockade at the end
of surgery is controversial.Case Reports in Anesthesiology 3
Response to muscle relaxants is unpredictable. Patients
mayberesistanttosuccinylcholineduetoadiminishednum-
ber of available receptors but sensitive to nondepolarizing
agents. Therefore, muscle relaxants should be avoided, and
shorter-acting drugs chosen and closely monitored.
Some argue that anticholinesterases and antimuscarinics
militate against eﬀorts to diﬀerentiate weakness due to inad-
equate neuromuscular transmission from cholinergic crisis
in the recovery room. They, therefore, prefer spontaneous
recovery and extubation when the patient has demonstrated
adequate parameters for extubation (e.g., head life, tongue
protrusion) [4, 5]. Total intravenous anesthesia (TIVA) for
the management of myasthenic patients has been reported.
The use of remifentanil as part of TIVA may alleviate some
hemodynamic instability. When feasible, many clinicians
prefer to utilize regional or local anesthetic techniques
[6]. Regional techniques may reduce or eliminate the need
for muscle relaxant in abdominal surgery. However, jet
ventilation carries its own risks, such as damage to tracheal
mucosa, subcutaneous emphysema, pneumomediastinum,
and pneumothorax [3].
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